MergerMay 4, 2026, 06:12 AM
Lisata Therapeutics Extends Tender Offer Deadline to May 29
AI Summary
Lisata Therapeutics, Inc. and Kuva Labs Inc. entered into an amendment and waiver to their previously announced Merger Agreement. The amendment extends the date by which Kuva Acquisition Corp. is obligated to commence the tender offer for Lisata's shares from April 13, 2026, to May 29, 2026. Kuva Labs also agreed to pay certain expenses of Lisata, up to $1.1 million in aggregate, until the offer commences. In exchange, Lisata agreed not to pursue claims against Kuva Labs during this period and will irrevocably waive certain claims related to the prior delay upon the offer's commencement and full payment.
Key Highlights
- Tender offer commencement deadline extended from April 13, 2026, to May 29, 2026.
- Kuva Labs Inc. to pay Lisata Therapeutics' expenses up to $1.1 million in aggregate.
- Lisata Therapeutics agrees not to pursue claims against Kuva Labs until May 29, 2026.
- Lisata to waive claims for prior delay upon offer commencement and full payment of expenses.
- Interim operating payments include $175,000 by May 5 and $175,000 by May 7, 2026.
- Additional interim payments: $250,000 by May 12, $250,000 by May 19, and $250,000 by May 26, 2026.
Price Impact
More from LSTA